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Background: Chronic Achilles tendinosis is a common problem. When evaluating and comparing different
therapies there is a need for reliable imaging methods. Our aim was to evaluate if chronic Achilles tendinosis
affects the dynamic contrast-enhancement in the tendon and its surroundings and if short-term eccentric
calf-muscle training normalizes the dynamic contrast-enhancement.
Methods: 20 patients with chronic Achilles tendinopathy were included. Median duration of symptoms was
31 months (range 6 to 120 months). Both Achilles tendons were examined with dynamic contrast enhanced MRI
before and after a 12- week exercise programme of eccentric calf-muscle training. The dynamic MRI was evaluated
in tendon, vessel and in fat ventrally of tendon. Area under the curve (AUC), time to peak of signal, signal increase
per second (SI/s) and increase in signal between start and peak as a percentage (SI%) was calculated. Pain and
performance were evaluated using a questionnaire.
Results: In the fat ventrally of the tendon, dynamic contrast enhancement was significantly higher in the
symptomatic leg compared to the contralateral non-symptomatic leg before but not after treatment. Despite
decreased pain and improved performance there was no significant change of dynamic contrast enhancement in
symptomatic tendons after treatment.
Conclusion: In Achilles tendinosis there is an increased contrast enhancement in the fat ventrally of the tendon.
The lack of correlation with symptoms and the lack of significant changes in tendon contrast enhancement
parameters do however indicate that dynamic enhanced MRI is currently not a useful method to evaluate chronic
Achilles tendinosis.Background
Chronic Achilles tendinosis is common especially in
athletes but also in non- athletes [1,2]. Deranged vas-
culature is thought to be involved in the pathogenesis
[3]. A pathologic vascularity not only inside the tendon
but also outside, ventrally of the tendon, has been shown
[4]. Several treatment approaches have been applied [5-9].
When evaluating and comparing different therapies there
is a need of reliable imaging methods since evaluation
with clinical examination and questionnaires cannot be
fully blinded. By using ultrasound tendon thickening,
hypoechoic areas and neovascularisation can be visualized* Correspondence: anna.gardin@karolinska.se
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reproduction in any medium, provided the orand quantified [4,10,11]. Unfortunately ultrasound is
user dependent and reproducibility is limited [12]. MRI
techniques focus on measuring tendon thickening and
on quantifying areas of intratendinous high signal
[10,11,13]. By also administering intravenous gadolinium
contrast media the intratendinous signal changes have
been shown to be more pronounced [11]. After histo-
pathological correlates it was hypothesized that the
increased enhancement of the affected tendons from
intravenous gadolinium might be explained by a local
pathologically increased amount of glycosaminoglycans,
a macromolecule with high water containing capacity.
In a previous publication we have shown that the
absolute signal intensity was increased in symptomatic
tendons before training and that it decreases towards
normal values after three months of eccentric training
[14]. Comparison of intratendinous signal between
different occasions is however not fully reliable dueLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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such as placement of coils, temperature and normal
T1/T2 fluctuations affecting the signal intensity. To
avoid that methodological error a semi-quantitative
scale was used when performing a follow-up of these
patients 4 years after training [15]. The intratendionous
signal of the previously affected tendons was then
comparable to that of the non-symptomatic tendons.
Use of semi-quantitative scales does however have a
lower sensitivity than quantitative measurements due
to influence from inter- and intra-observer variation.
Further improvements of techniques to quantify Achilles
tendinosis are therefore needed.
At dynamic contrast-enhanced MR imaging (DEMRI)
of the Achilles tendon several images are obtained at
fixed time-points after the injection of an MRI contrast
agent. By analyzing the changes in signal intensity it is
possible to calculate the physiologic kinetics. This
gives information about tissue vascularity, perfusion
and capillary permeability [16,17]. This technique should
in theory be ideal to quantify the histopathological
changes that have been observed in chronic Achilles
tendinosis including increased vascularity, abnormal
fiber structure, focal variation in cellularity and increased
areas of non-collagen extracellular matrix [18,19]. The
micro vascularisation in Achilles tendinosis has been
evaluated during one year in a pilot study using MRI
time-intensity curves together with power Doppler
ultrasound [20].
The aim of this study was to evaluate the dynamic
contrast-enhancement in Achilles tendinosis and if an
altered dynamic contrast-enhancement is normalized
after a short-term eccentric calf-muscle training. We
also evaluated if the dynamic contrast-enhancement is
correlated to the subjective symptoms.
Patients
This study consists of a subgroup of a previously pub-
lished patient material [14]. In that study intratendinous
MRI signal, tendon volume and pain and performance
before and after three months of eccentric training
was evaluated. That study and the present study were
approved by the local ethics committee at Karolinska
Institutet and informed consent was obtained from
each patient.
Because of technical problems when performing the
DEMRI (three cases of incorrect contrast injection
timing, one with extravasation and in one case intolerance
of the contrast agent) only 20 patients of the original
25 patients participated in this dynamic contrast study.
The 20 patients (14 male and 6 females) were aged 28
to 70 years (median 51). Achilles tendinosis was defined
as pain and local tenderness of the midportion of the
Achilles tendon 2 to 7 cm proximal to the tendoninsertion. Median duration of symptoms was 31 months
(range 6 to 120 months). In 9 of the 20 patients the
Achilles tendon symptoms were sports related; at the
time when symptoms appeared 7 patients practiced
recreational running and one of them also practiced
skiing and another also basketball. One patient practiced
golf and one patient related the symptoms to snowboard
skiing. The remaining 11 were regarded as idiopathic.
Previous corticosteroid injections and systemic diseases
such as rheumatic disease constituted exclusion criteria.
14 of the 20 patients had unilateral symptoms whereas
6 of the patients also had a history of symptoms in the
contralateral Achilles tendon. In patients with bilateral
symptoms, the Achilles tendon with most symptoms
was considered as the symptomatic tendon. One of the
20 patients had had an operation in the contralateral
tendon 5 years previous to this study. None of the
other patients had had any previous treatment other
than pain medication.
Treatment
The eccentric exercise programme followed a model
developed by Alfredson et al. [5]. Eccentric loading of
the calf was done in two ways; with the knee straight and
with the knee bent. The eccentric loading was performed
with all body weight on the symptomatic side. Each of
the two exercises was done with 15 repetitions in 3 sets
(3 × 15 repetitions) twice a day for 12 weeks. The patients
were instructed to train their symptomatic side, but it
is possible that some patients might have also trained
the non-symptomatic side. To ensure compliance the
patients saw a physiotherapist on two occasions and were
contacted once on telephone. Symptoms were evaluated
using a questionnaire, modified from a classification by
Curwin and Stanish, grading pain on a six-level scale
and performance on a four-level scale [21] (Table 1).
MRI acquisition
Both Achilles tendons were examined with Dynamic MRI
at two occasions, before (DEMRI 1) and after three
months of heavy loaded eccentric calf-muscle training
(DEMRI 2) using a 1.5 Tesla Magnetom Vision (Siemens,
Erlangen, Germany). Both Achilles tendons were examined
simultaneously using a commercially available CP-flexible
21 × 52 cm coil centered over the Achilles tendons. The
patients were examined in a supine position with the
feet in a resting position in the coil. The sequence used
for the dynamic MRI series was a sagittal Flash 2D with
3 mm slice thickness, TR/TE 50/9 ms, flip angle 40°, FOV
180 × 180 mm, matrix 128 × 256 mm, time of acquisition
31 seconds. The contrast agent (gadopentetate dime-
glumine, Magnevist®, Schering or gadodiamid, Omniscan®,
Nycomed Amersham), 0.2 mmol/kg body weight, was
injected by an auto-injector, 2 ml/second, via a catheter
Table 1 Classification of the level of pain and functional impairment
Intensity Level Pain Level Performance
Mild 1 None 1 Normal
2 With extreme exertion only, not intense 1 Normal
Moderate 3 Starts with activity, lasts for 1–2 hours after activity 2 Performance may be affected
4 With any athletic activity, increase during activity 3 Performance level significantly
decreased
Severe 5 Immediately upon any activity involving tendon. Sudden increase
in pain if activity is continued, lasts for 12–24 hours
3 Performance markedly
curtailed or prevented
6 During daily activities 4 Unable to participate
Modified from Curwin & Stanish [18].
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acquisition of the Dynamic MR series was started at
the same time as the contrast injection. The Dynamic
MR series lasted 5 minutes and 20 seconds, consisting
of 5 sets with an interval of 40-seconds followed by
two sets with an interval of 80 seconds. Every set had
four sagittal slices, two from the symptomatic tendon
and two from the contralateral tendon.Evaluation of dynamic MRI
The Dynamic MRI series of the symptomatic and the
contralateral tendons, before and after three months of
eccentric training, were evaluated on a Hermes workstation
(Nuclear Diagnostics, Stockholm, Sweden). From the
two sagittal slices obtained from each Achilles tendon
in every set, the most centered one was chosen by
visual estimation. A circular ROI with a radius of 2 mm
was placed in the thickest part of the tendon, and in
the horizontal direction the area with the highest signal
was chosen (Figure 1). In the case of no visible signal
increase the ROI was placed in the centre of the thickest
part of the tendon. The ROI’s distance from the upper
posterior margin of the calcaneal bone was noted to
ensure correct placement of the ROI at the follow up
examination. One ROI with a radius of 2 mm was
placed in a vessel ventrally of the tendon. One ROI
with a radius of 5 mm was placed in the fat ventrally of
the tendon. The three ROI:s placed in the first image of
the dynamic series were then copied and pasted into
the following images of the dynamic series. The signal
intensity of each ROI was then plotted as a function of
time, reflecting the contrast enhancement. Since signal
intensity is a relative value and changes proportionally,
the signal intensity at each point of the dynamic series
was normalized by dividing the signal intensity of all
subsequent intensity values with that obtained at the
start of contrast injection (SI0) (i.e. so that SI0 = 1). The
area under the curve (AUC) was then calculated for
each ROI from the start of contrast injection until
320 seconds later, using the trapezoid method [22].AUC ¼ SI0 þ SI1ð Þ  40 seconds=2
þ SI1 þ SI2ð Þ  40 seconds=2
þ SI2 þ SI3ð Þ  40 seconds=2
þ SI3 þ SI4ð Þ  40 seconds=2
þ SI4 þ SI5ð Þ  80 seconds=2
þ SI5 þ SI6ð Þ  80 seconds=2
−SI0  320 seconds
In addition to AUC, time to peak (i.e. the time from
start of contrast injection until maximum signal), SI/s
(i.e. the increase of signal intensity per second until
maximum signal) and SI% (i.e. the increase in signal
between start and peak, expressed in percent) was cal-
culated for each ROI.
Statistical methods and data management
Statistical comparisons in order to test differences
between the symptomatic side and the contralateral
side and between DEMRI 1 and DEMRI 2 was made
by use of paired Student’s t-test for correlated variables.
The Spearman rank order correlation was used in order
to test independence between variables. The study employs
multiple hypothesis testing, where each hypothesis was
analyzed separately and the existence of patterns in and
the consistency of the results were considered in the
analysis. Probability values (p-value) <0.05 were considered
significant.
Results and discussion
Comparison between symptomatic and contralateral
ankle in the 14 patients with unilateral symptoms
In the fat ventrally of the symptomatic tendon, AUC, SI/s
and SI% was significantly higher than that of the
asymptomatic side before, but not after, eccentric training
(Table 2). In the tendons there was no statistically sig-
nificant difference of mean AUC, SI/s, SI% or time to
peak between the symptomatic and the contralateral
asymptomatic tendons before or after eccentric training.
After, but not before training, there was a significantly
Figure 1 Proton density weighted turbo spin-echo image of the right Achilles tendon prior to eccentric training in a 45-year-old man
with chronic Achilles tendinosis. There is a fusiform thickening of the mid-portion of the Achilles tendon with increased intratendinous signal.
The measurement regions of interest were placed in: A = the tendon, B = the fat ventrally of the tendon and C = a vessel.
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tomatic tendon side compared to the asymptomatic side
(238 seconds (SD 97) and 289 seconds (SD 59)
respectively, p < 0.05).Comparison between before and after eccentric training
in 20 patients
Mean AUC, SI/s, and SI% in tendon, fat and vessel did
not change during eccentric training. Neither was there
any significant change in time to peak in the symptomatic
tendons. In the tendon of the contralateral side (the
asymptomatic or the least symptomatic tendon) there
was a significantly shorter time to peak after training
(Table 3).Pain and performance
The median level of pain decreased from 5 to 3 after
training (p < 0.01 in all 20 patients and p < 0.05 in 14
patients with unilateral symptoms). The median level
of performance improved from 4 to 3 after training(p < 0.01 in all 20 patients and p < 0.001 in 14 patients
with unilateral symptoms).
Correlation to pain and performance
Tendon
AUC, time to peak, SI/s, or SI% in the symptomatic
tendons (n = 20) did not correlate to the level of per-
formance or pain neither before nor after the exercise
programme. In the 14 contralateral non-symptomatic
tendons, AUC and time to peak correlated to pain before
training (r = 0.53 and r = 0.59 respectively, p < 0.05 both)
but not after. SI/s or SI% in the 14 contralateral non-
symptomatic tendons had no correlation to pain or
performance.
Fat
In the 20 symptomatic sides, time to peak in the fat
ventrally of the tendon correlated both to pain (r = 0.61,
p < 0.01) and performance (r = 0.50, p < 0.05) after,
but not before, training. Time to peak in the fat had
an inverted correlation to performance after training
Table 2 Dynamic contrast enhancement in tendon and in fat ventrally of tendon
Symptomatic Contralateral Symptomatic Contralateral
Before training Before training After training After training
AUC tendon 80 (65) NS 66 (59) 76 (53) NS 52 (65)
SI/s 103 tendon 1.8 (1.5) NS 1.6 (0.8) 1.9 (1.2) NS 3.0 (4.7)
SI% tendon 41 (21) NS 38 (18) 38 (19) NS 33 (26)
AUC fat 31 (15)*** 20 (11) 26 (15) NS 22 (13)
SI/s x 103 fat 0.44 (0.24)* 0.32 (0.13) 0.43 (0.20) NS 0.34 (0.16)
SI% fat 14.5 (7.4)** 9.5 (4.9) 12.1 (6.3) NS 10.6 (5.4)
Mean AUC, SI/s and SI% in the symptomatic and contralateral side measured in the tendon and in the fat ventrally of the tendon before and after eccentric
training, in 14 patients with unilateral symptoms. One standard deviation is provided within parenthesis. The significance of mean difference between the
symptomatic and contralateral side has been noted. *** = p < 0.001, ** = p < 0.01, * = p < 0.05, NS = Not Significant.
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tomatic sides.
Vessel
In the 20 symptomatic sides SI/s in vessel correlated to
performance before (r = 0.4, p < 0.05) but not after
training. Time to peak had an inverted correlation to
performance in the 20 symptomatic sides (r = −0.52,
p < 0.05). In the 14 contralateral non-symptomatic sides
AUC and SI/s in vessel had an inverted correlation to
pain after training (r = −0.53 and r = −0.57 respectively,
p < 0.05 both).
Discussion
In this study dynamic contrast-enhanced MR imaging
was performed in 20 patients with Achilles tendinosis
before and after three months of eccentric calf-muscle
training. In the fat ventrally of the tendon there was a
significantly increased contrast enhancement in the
symptomatic side compared to the contralateral non-
symptomatic side before treatment but not after three
months of treatment. However, in contradiction to this
result there was no difference when comparing before to
after treatment. Inside the tendon there was no difference
of contrast enhancement in the symptomatic tendon
compared to the contralateral tendon before or after
the training programme. This finding is in disagreement
with a previous study by Shalabi et al [23], and a study by
Richards et al [20], where both these studies could showTable 3 Mean time to peak contrast enhancement
Symptomatic Contralate
Before training Before train
Tendon 240 (89) 250 (78)
Vessel 260 (76) 270 (61)
Fat 300 (64) 300 (57)
Mean time in seconds from start of contrast injection to peak contrast enhancemen
and contralateral ankle of 20 patients with chronic achilles tendinosis before and af
provided within parenthesis. The p-value comparing time from start to peak contra
noted. * = p < 0.05, NS = Not Significant.an increased AUC on the symptomatic tendon before
treatment. This difference might be due to differences in
duration of symptoms. The patients in Shalabi’s study had
a median symptom duration of 12 months compared to
the 31 month median duration in our study. In Richards’
study the duration was not reported. It might therefore be
that the AUC had already returned to baseline due to the
relatively long duration of the symptoms in our chronic
tendinosis patients at the time of inclusion in our study.
In the present study a stronger contrast enhancement
in the fat ventrally of the tendon in the symptomatic
compared to the contralateral non-symptomatic tendon
side was observed before, but not after three months of
treatment. The observed contrast enhancement in the
fat ventrally of the symptomatic tendon in the present
study may be due to an increased vascularity but also to
increased permeability because mean time to peak signal
in the fat ventrally of the tendon in the symptomatic side
was 40 seconds longer compared to the corresponding
vessel (Table 3). Thus, it might be that the vascularity of
the areas ventrally to the tendon [4], is an early marker
of treatment effect, while the changes in the tendon need
longer time to disappear. However, when evaluating the
treatment effect by comparing the enhancement before
with that of after training no significant effect could be
observed, probably due to lack of statistical power. The
clinical value of evaluating the vascularity of pretendinous
fat is therefore low. The histopathological changes in
Achilles tendinosis such as vascular proliferation, focalral Symptomatic Contralateral
ing After training After training
240 (100) NS 190 (110)*
240 (89) NS 270 (78) NS
290 (53) NS 300 (42) NS
t in tendon, vessel and in the fat ventrally of the tendon in the symptomatic
ter three months of eccentric calf-muscle training. One standard deviation is
st enhancement before and after three months of eccentric training has been
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structure, and increased areas of non-collagen extra cellu-
lar matrix have previously been shown to correlate with
increased intratendinous signal at MRI of the tendon
[2,11,17,18,10]. An increased contrast enhancement at
MRI in pathologic tissue is thought to reflect an increased
vascularity and/or an increased capillary permeability
[16,17]. By using ultrasound and colour Doppler an
increased vascularity mainly inside but also outside
ventrally of the symptomatic tendon has previously been
shown [4]. The observed contrast enhancement in
the fat ventrally of the symptomatic tendon observed
in the present study may thus be due to an increased
vascularity. However, in the study by Shalabi et al [23]
no correlation between histological increase in vas-
cularity and increased AUC of contrast enhancement
could be shown.
In a recent review of loading treatment programmes
the majority of studies did not find any association
between improved imaging parameters and clinical
outcome in Achilles tendinosis [24]. A pilot study eva-
luating longitudinal microvascularisation of Achilles
tendinosis showed that pain is not invariably associated
with microvascularity [20]. This may explain the lack of
correlation with symptoms in our study. Despite of a
significant clinical improvement with both improved
performance and decreased pain during the training
programme there were almost no significant correlations
between dynamic contrast enhancement in the symp-
tomatic tendons to pain or performance. AUC and time
to peak measured in the fat ventrally of the tendon at
three months after treatment were related to pain and
there was a relationship between AUC and SI/s measured
in vessel before treatment to performance. There was
no significant change of contrast enhancement in tendon,
fat or vessel before compared to after 3 months of
eccentric training.
In this study 20 patients with chronic achilles tendinosis
were studied. In nine of those the tendinosis was sports
related, while 11 were idiopathic. Although most of the
sports related were due to running (n = 7) the hetero-
genous material in our study is a limitation. When our
study was planned and conducted the questionnaire
by Curwin and Stanish was used at our institution.
That questionnaire is easier to use for the patients,
but to enable comparisons with other studies it might
have been better if the VISA-A questionnaire had
been used.
The lack of correlation with symptoms indicates that
dynamic enhanced MRI is currently not a useful method
to evaluate chronic Achilles tendinosis compared to MRI
without contrast media. Further development of imaging
methods to visualize the pathology at chronic Achilles
tendinosis is necessary. For example, the use of ultra shortecho time (UTE) at MRI makes it possible to demonstrate
features that are not apparent with conventional MRI
sequences [25] which may make it possible to quantify
the subtle signal changes at Achilles tendinosis and its
treatment.
Conclusion
In conclusion there was an increased contrast-media
enhancement in the fat ventrally of the tendon in Achilles
tendinosis that disappeared after three months of training,
but otherwise dynamic contrast enhanced MRI did not
show any additional value.
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